328 related articles for article (PubMed ID: 31513917)
1. Exploring the resistance mechanisms in Trichosporon asahii: Triazoles as the last defense for invasive trichosporonosis.
Padovan ACB; Rocha WPDS; Toti ACM; Freitas de Jesus DF; Chaves GM; Colombo AL
Fungal Genet Biol; 2019 Dec; 133():103267. PubMed ID: 31513917
[TBL] [Abstract][Full Text] [Related]
2. Implication of efflux pumps and
Abbes S; Sellami H; Neji S; Trabelsi H; Makni F; Ayadi A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33688802
[No Abstract] [Full Text] [Related]
3. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
[TBL] [Abstract][Full Text] [Related]
4. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Sun W; Su J; Xu S; Yan D
J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
[TBL] [Abstract][Full Text] [Related]
5. [Antifungal susceptibility and drug-resistant mechanism of Trichosporon].
Kushima H; Tokimatsu I; Ishii H; Kadota J
Med Mycol J; 2015; 56(4):J123-8. PubMed ID: 26617108
[TBL] [Abstract][Full Text] [Related]
6. Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B.
Iturrieta-González IA; Padovan AC; Bizerra FC; Hahn RC; Colombo AL
PLoS One; 2014; 9(10):e109553. PubMed ID: 25360765
[TBL] [Abstract][Full Text] [Related]
7. Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients.
Xia Z; Yang R; Wang W; Cong L
Mycopathologia; 2012 Mar; 173(2-3):127-33. PubMed ID: 21979867
[TBL] [Abstract][Full Text] [Related]
8. Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system.
Treviño M; García-Riestra C; Areses P; García X; Navarro D; Suárez FJ; López-Dequidt IA; Zaragoza O; Cuenca-Estrella M
Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1497-503. PubMed ID: 24718613
[TBL] [Abstract][Full Text] [Related]
9. Correlation of
Francisco EC; de Almeida Junior JN; Queiroz-Telles F; Aquino VR; Mendes AVA; de Oliveira Silva M; Castro PTOE; Guimarães T; Ponzio V; Hahn RC; Chaves GM; Colombo AL
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318016
[No Abstract] [Full Text] [Related]
10. Cloning of the lanosterol 14-α-demethylase ( ERG11 ) gene in Trichosporon asahii: a possible association between G453R amino acid substitution and azole resistance in T. asahii.
Kushima H; Tokimatsu I; Ishii H; Kawano R; Shirai R; Kishi K; Hiramatsu K; Kadota J
FEMS Yeast Res; 2012 Sep; 12(6):662-7. PubMed ID: 22621704
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and Antifungal Susceptibility of Infections Caused by
Singh S; Capoor MR; Varshney S; Gupta DK; Verma PK; Ramesh V
Indian J Med Microbiol; 2019; 37(4):536-541. PubMed ID: 32436877
[TBL] [Abstract][Full Text] [Related]
12. Disseminated Trichosporon asahii infection in a combined liver-kidney transplant recipient successfully treated with voriconazole.
Sah R; Soin AS; Chawla S; Wadhwa T; Gupta N
Immun Inflamm Dis; 2019 Sep; 7(3):125-129. PubMed ID: 31006179
[TBL] [Abstract][Full Text] [Related]
13. Antifungal Activity and Potential Action Mechanism of Allicin against Trichosporon asahii.
Yang X; Bai S; Wu J; Fan Y; Zou Y; Xia Z; Ao J; Chen T; Zhang M; Yang R
Microbiol Spectr; 2023 Jun; 11(3):e0090723. PubMed ID: 37199655
[TBL] [Abstract][Full Text] [Related]
14. Biofilm formation and antifungal susceptibility of Trichosporon asahii isolates from Mexican patients.
Montoya AM; Elizondo-Zertuche M; Treviño-Rangel RJ; Becerril-García M; González GM
Rev Iberoam Micol; 2018; 35(1):22-26. PubMed ID: 29287630
[TBL] [Abstract][Full Text] [Related]
15. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres.
Francisco EC; de Almeida Junior JN; de Queiroz Telles F; Aquino VR; Mendes AVA; de Andrade Barberino MGM; de Tarso O Castro P; Guimarães T; Hahn RC; Padovan ACB; Chaves GM; Colombo AL
Clin Microbiol Infect; 2019 Jul; 25(7):909.e1-909.e5. PubMed ID: 30991116
[TBL] [Abstract][Full Text] [Related]
16. Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma.
Itoh K; Iwasaki H; Negoro E; Shigemi H; Tokimatsu I; Tsutani H; Yamauchi T
Mycopathologia; 2021 Mar; 186(1):113-117. PubMed ID: 33389484
[TBL] [Abstract][Full Text] [Related]
17. A New Amino Acid Substitution at G150S in Lanosterol 14-α Demethylase (Erg11 protein) in Multi-azole-resistant Trichosporon asahii.
Kushima H; Tokimatsu I; Ishii H; Kawano R; Watanabe K; Kadota JI
Med Mycol J; 2017; 58(1):E23-E28. PubMed ID: 28250360
[TBL] [Abstract][Full Text] [Related]
18. Current knowledge of Trichosporon spp. and Trichosporonosis.
Colombo AL; Padovan AC; Chaves GM
Clin Microbiol Rev; 2011 Oct; 24(4):682-700. PubMed ID: 21976604
[TBL] [Abstract][Full Text] [Related]
19. Intergenic spacer (IGS-1) region sequence-based identification, genotypic analysis, and antifungal susceptibility of clinical Trichosporon species.
Parashar A; Rastogi V; Prakash H; Pandey A; Rudramurthy SM
Indian J Med Microbiol; 2023; 45():100390. PubMed ID: 37573054
[TBL] [Abstract][Full Text] [Related]
20. Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients.
Mekha N; Sugita T; Ikeda R; Nishikawa A; Autthateinchai R; Poonwan N; Sawanpanyalert P
Mycopathologia; 2010 Jan; 169(1):67-70. PubMed ID: 19609716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
